Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2012
11/27/2012US8318744 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
11/27/2012US8318742 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
11/27/2012US8318721 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
11/27/2012US8318480 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
11/27/2012US8318213 Aqueous extract of stems or leaves or stems and leaves of one or more Cissus quandragularis plants to promote weight loss; combined with chitosan and amylase inhibitor
11/27/2012CA2577745C Hcv inhibiting bi-cyclic pyrimidines
11/27/2012CA2531505C (20s)-1.alpha.-hydroxy-2-methylene-19-nor-vitamin d3 and its uses
11/22/2012WO2012158672A2 Compounds for use in treatment of mucositis
11/22/2012WO2012158517A1 The use of purified 2'-fucosyllactose, 3-fucosyllactose and lactodifucotetraose as prebiotics
11/22/2012WO2012158048A1 A dietary supplement
11/22/2012WO2012158002A1 Medicinal preparation "renessans" having an antibacterial, anti-ulcerous and immuno-modulating action
11/22/2012WO2012157752A1 Pharmaceutical composition containing loxoprofen
11/22/2012WO2012157746A1 Therapeutic drug for autoimmune disease
11/22/2012WO2012157721A1 Liposome containing pyrroloquinoline quinone and sugar
11/22/2012WO2012157647A1 Method for selecting chemotherapy for gastric cancer patient using combination drug of tegafur, gimeracil and oteracil potassium and egfr inhibitor
11/22/2012WO2012157479A1 Ctrp6 which can be used as therapeutic and prophylactic agent for autoimmune diseases
11/22/2012WO2012157290A1 Prophylactic/ameliorating agent for non-alcoholic steatohepatitis
11/22/2012WO2012156951A1 Polymorph of rifaximin and process for the preparation thereof
11/22/2012WO2012155819A1 Hbv specific antibody
11/22/2012WO2012155227A1 Composition comprising a mixture of fibers
11/22/2012WO2012155220A1 Composition comprising a mixture of fibers
11/22/2012WO2012131656A3 Compounds for use as therapeutic agents affecting p53 expression and/or activity
11/22/2012WO2012126178A3 Pharmaceutical composition for treating hepatic disease
11/22/2012WO2012109605A8 Forms of rifaximin and uses thereof
11/22/2012WO2012102645A3 Pharmaceutical composition comprising the peptide glu-asp-gly and use for treating helicobacter pylori induced gastroduodenal diseases
11/22/2012WO2012096718A3 Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers, and liver health maintenance
11/22/2012US20120296403 Methods and compounds for muscle growth
11/22/2012US20120296088 Synthesis of udp-glucose: n-acylsphingosine glucosyl transferase inhibitors
11/22/2012US20120296072 N-terminally chemically modified protein compositions and methods
11/22/2012US20120295968 Pharmaceutical Composition Comprising Cannabinoids
11/22/2012US20120295961 Modulation of hepatitis b virus (hbv) expression
11/22/2012US20120295959 Treatment of rnase h1 related diseases by inhibition of natural antisense transcript to rnase h1
11/22/2012US20120295954 Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8
11/22/2012US20120295953 Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63
11/22/2012US20120295952 Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity
11/22/2012US20120295945 Buccal, polar and non-polar spray containing ondansetron
11/22/2012US20120295942 Pyrazolo[5,1b]oxazole Derivatives as CRF-1 Receptor Antagonists
11/22/2012US20120295934 New Hexahydrocyclopentapyrrolone, Hexahydropyrrolopyrrolone, Octahydropyrrolopyridinone and Octahydropyridinone Compounds
11/22/2012US20120295933 Treatment of copd, gastro-esophageal reflux disease (gerd), food allergies and other gastrointestinal conditions and disorders ameliorated by proper histamine management using a combination of histidine decarboxylase inhibators, lra drugs, anti-h1 and/or anti-h2 drugs
11/22/2012US20120295925 Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds
11/22/2012US20120295924 Thienopyrimidinedione derivatives as trpa1 modulators
11/22/2012US20120295922 Compounds For Use In Treatment Of Mucositis
11/22/2012US20120295909 Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application
11/22/2012US20120295900 1,3-oxazines as bace 1 and/or bace2 inhibitors
11/22/2012US20120295889 3-Arylamino Pyridine Derivatives
11/22/2012US20120295884 Complement pathway modulators and uses thereof
11/22/2012US20120295879 NK1 Antagonists
11/22/2012US20120295877 Therapeutic Compounds
11/22/2012US20120295850 Glp-1 receptor agonists to treat pancreatitis
11/22/2012US20120295849 Use of glp-1 receptor agonists for the treatment of gastrointestinal disorders
11/22/2012US20120295845 Imidazo-pyrazoles as gpr119 inhibitors
11/22/2012US20120295835 Sgef controls macular, corpus callosum and hippocampal function and development, liver homeostasis, functions of the immune system, fever response atherosclerosis and tumorogenic cell growth
11/22/2012US20120294954 Compositions including ginger for the amelioration or prevention of inflammatory conditions
11/22/2012US20120294946 Modulator
11/22/2012US20120294940 Rapidly disintegrating tablet in oral cavity
11/22/2012US20120294937 New pharmaceutical dosage form for the treatment of gastric acid-related disorders
11/22/2012US20120294928 Method of treating scars and b-catenin-mediated disorders using nefopam compounds
11/22/2012US20120294905 Lipid Formulated Compositions And Methods For Inhibiting Expression Of Transthyretin (TTR)
11/22/2012US20120294895 Protein a compositions and methods of use
11/22/2012US20120294887 Solid/liquid extraction
11/22/2012US20120294869 Methods for Treating Fatty Liver Disease
11/22/2012US20120294862 Antagonists of il-17a, il-17f, and il-23p19
11/22/2012US20120294861 Fgfr1 agonists and methods of use
11/22/2012US20120294858 Use of long-acting recombinant human soluble tumor necrosis factor alpha receptor in manufacture of a medicament for the treatment and/or prophylaxis of hepatic failure
11/22/2012US20120294849 Use of wf10 for treating allergic asthma, allergic rhinitis and atopic dermatitis
11/22/2012US20120294844 Methods And Kits For Topical Application, Removal, And Inactivation Of Therapeutic Or Cosmetic Toxin Compositions
11/22/2012US20120294840 Use Of Purified 2'-Fucosyllactose, 3-Fucosyllactose and Lactodifucotetraose as Prebiotics
11/22/2012US20120294834 Regeneration of, reestablishing function in and replacing microvasculature in organs and tissues
11/22/2012US20120294827 Polymer gel formulation
11/22/2012US20120294822 Use of anti-cgrp antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated cgrp levels
11/22/2012US20120294812 Oral care compositions
11/22/2012US20120294797 Anti-cgrp compositions and use thereof
11/22/2012CA2844765A1 Polymorph of rifaximin and process for the preparation thereof
11/22/2012CA2836215A1 Compound useful for preventing or treating irritable bowel syndrome and composition including same
11/22/2012CA2836099A1 Compounds for use in treatment of mucositis
11/21/2012EP2524697A1 Therapeutic agent for promoting recovery of animal under medical treatment
11/21/2012EP2523686A2 Liver targeting domain antibodies
11/21/2012CN202542107U Lansoprazole and hydrotalcite composition
11/21/2012CN102791704A Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5)
11/21/2012CN102791687A Novel inhibitors of hepatitis C virus replication
11/21/2012CN102791293A Liver targeting molecules
11/21/2012CN102788859A Processed rhubarb or/and raw rhubarb detection method
11/21/2012CN102787119A Products and methods for treatment and/or prevention of virus infections
11/21/2012CN102787056A Kidney tonifying medicinal liquor
11/21/2012CN102786592A Specific HBV antibody
11/21/2012CN102786574A Glycyrrhetinic acid crystal A substance, its preparation method, and its applications in medicines and healthcare products
11/21/2012CN102786573A Glycyrrhetinic acid crystal B substance, its preparation method, and its applications in medicines and healthcare products
11/21/2012CN102786513A Omeprazole crystal E substance, its preparation method and its applications in medicines and healthcare products
11/21/2012CN102786476A Novel compounds as opioid receptor modulators
11/21/2012CN102786462A Arbidol hydrochloride crystal B, its preparation method, and its applications in medicines and healthcare products
11/21/2012CN102786418A Chlorogenic acid crystal II characterization and preparation methods, and applications of chlorogenic acid crystal II in medicines and healthcare products
11/21/2012CN102786417A Chlorogenic acid crystal III characterization and preparation methods, and applications of chlorogenic acid crystal III in medicines and healthcare products
11/21/2012CN102784398A Composition comprising endostatin adopted as delivery system and chemically-synthesized RNA interference molecule, and application thereof
11/21/2012CN102784383A Methods for preventing mitochondrial permeability transition
11/21/2012CN102784379A Method for preparing gingers
11/21/2012CN102784378A Traditional Chinese medicine preparation for treating sub-health
11/21/2012CN102784374A Traditional Chinese medicine composition for treating cold stomachache
11/21/2012CN102784366A Medical composition with function of decanting and protecting liver
11/21/2012CN102784363A Traditional Chinese medicine composition for treating pancreatic cancer and preparation method thereof
11/21/2012CN102784354A Chinese medicinal powder treating ulcer of stomach and duodenum
1 ... 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 ... 1258